2024

1. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force

   Bipolar Disorders, Vol. 26, Núm. 3, pp. 216-239